Clinical Microbiology Reviews, Oct 1997, 781-791, Vol 10, No. 4
HF Chambers
Methicillin resistance in staphylococci is determined by mec, composed of
50 kb or more of DNA found only in methicillin-resistant strains. mec
contains mecA, the gene for penicillin-binding protein 2a (PBP 2a); mecI
and mecR1, regulatory genes controlling mecA expression; and numerous other
elements and resistance determinants. A distinctive feature of methicillin
resistance is its heterogeneous expression. Borderline resistance, a
low-level type of resistance to methicillin exhibited by strains lacking
mecA, is associated with modifications in native PBPs, beta-lactamase
hyperproduction, or possibly a methicillinase. The resistance phenotype is
influenced by numerous factors, including mec and beta-lactamase (bla)
regulatory elements, fem factors, and yet to be identified chromosomal
loci. The heterogeneous nature of methicillin resistance confounds
susceptibility testing. Methodologies based on the detection of mecA are
the most accurate. Vancomycin is the drug of choice for treatment of
infection caused by methicillin-resistant strains. PBP 2a confers cross-
resistance to most currently available beta-lactam antibiotics.
Investigational agents that bind PBP 2a at low concentrations appear
promising but have not been tested in humans. Alternatives to vancomycin
are few due to the multiple drug resistances typical of
methicillin-resistant staphylococci.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
Medical Service, San Francisco General Hospital 94143, USA. chipc@itsa.ucsf.edu
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»